![Table 2: Adjusted Stroke and Thromboembolism Rates for CHA2DS2-Vasc Scores and Risk Categories | Radcliffe Cardiology Table 2: Adjusted Stroke and Thromboembolism Rates for CHA2DS2-Vasc Scores and Risk Categories | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/Table-2-Adjusted-Stroke-and-Thromboembolism-Rates.png)
Table 2: Adjusted Stroke and Thromboembolism Rates for CHA2DS2-Vasc Scores and Risk Categories | Radcliffe Cardiology
![È sempre indicata una terapia anticoagulante orale in pazienti con Fibrillazione atriale e punteggio CHA2DS2-VASc 1? - ATBV È sempre indicata una terapia anticoagulante orale in pazienti con Fibrillazione atriale e punteggio CHA2DS2-VASc 1? - ATBV](https://atbv.it/wp-content/uploads/2016/01/PATTI-Chads-Vasc-F1.jpg)
È sempre indicata una terapia anticoagulante orale in pazienti con Fibrillazione atriale e punteggio CHA2DS2-VASc 1? - ATBV
![Frontiers | CHA2DS2-VASc Score as a Predictor of New-Onset Atrial Fibrillation After Catheter Ablation of Typical Atrial Flutter Frontiers | CHA2DS2-VASc Score as a Predictor of New-Onset Atrial Fibrillation After Catheter Ablation of Typical Atrial Flutter](https://www.frontiersin.org/files/Articles/525765/fphys-11-00558-HTML/image_m/fphys-11-00558-g001.jpg)
Frontiers | CHA2DS2-VASc Score as a Predictor of New-Onset Atrial Fibrillation After Catheter Ablation of Typical Atrial Flutter
![Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914919306034-gr1.jpg)
Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect
![Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/3-Table2-1.png)
Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![Table 3 from Use of CHA2DS2-VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study. | Semantic Scholar Table 3 from Use of CHA2DS2-VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1cfc09b8139144dbe3a3b3a90142d28b6f4d0ab4/4-Table3-1.png)
Table 3 from Use of CHA2DS2-VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study. | Semantic Scholar
![The role of CHADS2 and CHA2DS2‐VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population‐based study - Saliba - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online Library The role of CHADS2 and CHA2DS2‐VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population‐based study - Saliba - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f80630be-bf67-41ca-865d-38188fdc5ba9/jth13324-fig-0002-m.jpg)
The role of CHADS2 and CHA2DS2‐VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population‐based study - Saliba - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online Library
![Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation | BMC Nephrology | Full Text Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation | BMC Nephrology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12882-021-02384-0/MediaObjects/12882_2021_2384_Fig1_HTML.png)
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation | BMC Nephrology | Full Text
theartofcardiology - • New Flashcard • “CHADS-VASc Score for Atrial Fibrillation Stroke Risk” Remember to use this score whenever you're deciding if anticoagulate or not a patient with atrial fibrillation. The assessment
![Validation of a Modified CHA 2 DS 2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation A Nationwide Cohort Study | Semantic Scholar Validation of a Modified CHA 2 DS 2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation A Nationwide Cohort Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/076faa2bd5c36c9c60ef64cb1e042eac360158fb/3-Table1-1.png)
Validation of a Modified CHA 2 DS 2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation A Nationwide Cohort Study | Semantic Scholar
![NOVITA & RSQUO; Nelle Linee Guida SULLA  terapia antitrombotica della fibrillazione atriale - ATBV NOVITA & RSQUO; Nelle Linee Guida SULLA  terapia antitrombotica della fibrillazione atriale - ATBV](https://atbv.it/wp-content/uploads/2015/02/fig-1-Focus-On-Marcucci.jpg)
NOVITA & RSQUO; Nelle Linee Guida SULLA  terapia antitrombotica della fibrillazione atriale - ATBV
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/d0d191e0-987d-42cc-983f-d06e4fcdb336/e003476fig02.jpg)